Clinical Trial Update: Comparison of Repaglinide and Gliclazide in Chinese Subjects With Type 2 Diabetes Never Received Oral Antidiabetic Drug Treatment [Phase 4]

View source ↗

Summary

This Phase 4 trial compares repaglinide and gliclazide in Chinese patients with type 2 diabetes who have never received oral antidiabetic therapy, evaluating co…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• Gliclazide (gliclazide)
• Repaglinide (Repaglinide)

Snippet

Sponsor: Novo Nordisk A/S | Conditions: Diabetes, Diabetes Mellitus, Type 2 | Phase 4 | Status: COMPLETED | Results posted: 2011-12-29